- Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Revascularization of Left Main Coronary Artery Disease
-
Park S, Park SJ, Park DW
- KMID: 2540391
- Korean Circ J.
- 2023 Mar;53(3):113-133.
- doi: 10.4070/kcj.2022.0333
Owing to a large-jeopardized myocardium, left main coronary artery disease (LMCAD) represents the substantial high-risk anatomical subset of obstructive coronary artery disease. For several decades, coronary artery bypass grafting (CABG) has... -
- CITED
-
- Close
- SHARE
-
- Close
- Contemporary Interventional Approach to Calcified Coronary Artery Disease
-
Sung JG, Lo ST, Lam H
- KMID: 2539484
- Korean Circ J.
- 2023 Feb;53(2):55-68.
- doi: 10.4070/kcj.2022.0303
Calcific coronary artery disease is an increasingly prevalent entity in the catheterization laboratory which has implications for stenting and expected outcomes. With new interventional techniques and equipment, strategies to favorably... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Health Literacy, Self-Efficacy, and Social Support on Health-related Quality of Life in Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention
-
Lee ES, Kim HS, Kang JH, Kim HK
- KMID: 2534894
- Korean J Adult Nurs.
- 2022 Oct;34(5):498-511.
- doi: 10.7475/kjan.2022.34.5.498
Purpose: This study aimed to determine the impact of health literacy, self-efficacy, and social support on the Health-Related Quality of Life (HRQoL) of Korean patients with Acute Coronary Syndrome (ACS)... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment delay and outcomes of ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention during the COVID-19 era in South Korea
-
Oh S, Jeong MH, Cho KH, Kim MC, Sim DS, Hong YJ, Kim JH, Ahn Y
- KMID: 2531478
- Korean J Intern Med.
- 2022 Jul;37(4):786-799.
- doi: 10.3904/kjim.2022.077
Background/Aims: Little is known about the clinical characteristics and treatment outcomes of ST-segment elevation myocardial infarction (STEMI) in Korea during the coronavirus disease 2019 (COVID-19) era. We aimed to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictors of recurrent acute myocardial infarction despite successful percutaneous coronary intervention
-
Lee SH, Jeong MH, Ahn JH, Hyun DY, Cho KH, Kim MC, Sim DS, Hong YJ, Kim JH, Ahn Y, Hwang JY, Kim W, Park JS, Yoon CH, Hur SH, Lee SR, Cha KS, on behalf of the KAMIR (Korea Acute Myocardial Infarction Registry)-NIH Investigators
- KMID: 2531477
- Korean J Intern Med.
- 2022 Jul;37(4):777-785.
- doi: 10.3904/kjim.2021.427
Background/Aims: Recurrent acute myocardial infarction (AMI) is an adverse cardiac event in patients with a first AMI. The predictors of recurrent AMI after the first AMI in patients who underwent... -
- CITED
-
- Close
- SHARE
-
- Close
- The Busan Regional CardioCerebroVascular Center Project’s Experience Over a Decade in the Treatment of ST-segment Elevation Myocardial Infarction
-
Lim K, Moon H, Park JS, Cho YR, Park K, Park TH, Kim MH, Kim YD
- KMID: 2532145
- J Prev Med Public Health.
- 2022 Jul;55(4):351-359.
- doi: 10.3961/jpmph.22.071
Objectives: The Regional CardioCerebroVascular Center (RCCVC) project was initiated to improve clinical outcomes for patients with acute myocardial infarction or stroke in non-capital areas of Korea. The purpose of this... -
- CITED
-
- Close
- SHARE
-
- Close
- Strategies for Renal Protection in Cardiovascular Interventions
-
Ali ZA, Escaned J, Dudek D, Radhakrishnan J, Galougahi KK
- KMID: 2530730
- Korean Circ J.
- 2022 Jul;52(7):485-495.
- doi: 10.4070/kcj.2022.0093
Coronary artery disease is highly prevalent in chronic kidney disease (CKD) and is a risk factor for contrast-associated acute kidney injury (CA-AKI), a complication of cardiovascular procedures that require contrast... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention
-
Park J, Han JK, Kang J, Chae IH, Lee SY, Choi YJ, Rhew JY, Rha SW, Shin ES, Woo SI, Lee HC, Chun KJ, Kim D, Jeong JO, Bae JW, Yang HM, Park KW, Kang HJ, Koo BK, Kim HS
- KMID: 2530736
- Korean Circ J.
- 2022 Jul;52(7):544-555.
- doi: 10.4070/kcj.2021.0395
Background and Objectives: The outcome benefits of β-blockers in chronic coronary artery disease (CAD) have not been fully assessed. We evaluated the prognostic impact of β-blockers on patients with chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- Off-hour presentation and outcomes for percutaneous coronary intervention in acute myocardial infarction with Killip III–IV
-
Oh S, Kim JH, Cho KH, Kim MC, Sim DS, Hong YJ, Ahn Y, Jeong MH
- KMID: 2529657
- Korean J Intern Med.
- 2022 May;37(3):591-604.
- doi: 10.3904/kjim.2021.539
Background/Aims: Acute myocardial infarction (AMI) is conventionally recognized as an urgent medical condition requiring timely and effective reperfusion therapy. However, the results of studies on the clinical outcomes in AMI... -
- CITED
-
- Close
- SHARE
-
- Close
- Low waist circumference prior to percutaneous coronary intervention predict the risk for end-stage renal disease: a nationwide Korean population based-cohort study
-
Bae EH, Lim SY, Yang EM, Oh TR, Choi HS, Kim CS, Ma SK, Kim B, Han KD, Kim SW
- KMID: 2529661
- Korean J Intern Med.
- 2022 May;37(3):639-652.
- doi: 10.3904/kjim.2021.313
Background/Aims: The obesity paradox has been known in end-stage renal disease (ESRD). However, the effect of body mass index (BMI) or waist circumference (WC) prior to percutaneous coronary intervention (PCI)... -
- CITED
-
- Close
- SHARE
-
- Close
- Osstem Cardiotec Centum Stent Versus Xience Alpine Stent for De Novo Coronary Artery Lesion: A Multicenter, Randomized, Parallel-Designed, Single Blind Test
-
Yoon CH, Jang J, Hur SH, Lee JH, Han SH, Hong SJ, Chang K, Chae IH
- KMID: 2529866
- Korean Circ J.
- 2022 May;52(5):354-364.
- doi: 10.4070/kcj.2021.0198
Background and objectives: To compare the safety and efficacy of a new everolimus-eluting stent with an abluminal-coated biodegradable polymer (Osstem Cardiotec Centum) with those of the Xience Alpine stent (Xience). Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time
-
Oh S, Hyun DY, Cho KH, Kim JH, Jeong MH
- KMID: 2529658
- Korean J Intern Med.
- 2022 May;37(3):605-617.
- doi: 10.3904/kjim.2021.204
Background/Aims: Rapid percutaneous coronary intervention (PCI) is the cornerstone of treatment for ST-elevation myocardial infarction (STEMI). However, there have been conflicting results regarding the differences in clinical outcomes between on-hours... -
- CITED
-
- Close
- SHARE
-
- Close
- De-escalation strategies of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for acute coronary syndrome
-
Song YB
- KMID: 2536922
- Cardiovasc Prev Pharmacother.
- 2022 Apr;4(2):63-69.
- doi: 10.36011/cpp.2022.4.e11
Antiplatelet therapy is important for reducing systemic and local thrombotic events in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Antiplatelet treatment regimens, along with dual antiplatelet... -
- CITED
-
- Close
- SHARE
-
- Close
- Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Is FFR-Guided Strategy Still Valuable?
-
Shin D, Rhee TM, Lee SH, Lee JM
- KMID: 2528022
- Korean Circ J.
- 2022 Apr;52(4):280-287.
- doi: 10.4070/kcj.2021.0416
Several studies have shown the benefit of complete revascularization (CR) over culprit-only percutaneous coronary intervention (PCI) in patients with ST-segment elevated myocardial infarction (STEMI) and multivessel disease (MVD). Nevertheless, optimal... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Primary Percutaneous Coronary Intervention without Stenting: Insight from Optimal Coherence Tomography
-
Roh JW, Kim Y, Lee OH, Im E, Cho DK, Choi D
- KMID: 2527522
- Yonsei Med J.
- 2022 Apr;63(4):399-404.
- doi: 10.3349/ymj.2022.63.4.399
For patients with acute myocardial infarction, current management guidelines recommend implantation of a drug-eluting stent, dual antiplatelet therapy (including potent P2Y 12 inhibitors) for at least 1 year, and maintenance... -
- CITED
-
- Close
- SHARE
-
- Close
- Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
-
Ki YJ, Lee BK, Park KW, Bae JW, Hwang D, Kang J, Han JK, Yang HM, Kang HJ, Koo BK, Kim DB, Chae IH, Moon KW, Park HW, Won KB, Jeon DW, Han KR, Choi SW, Ryu JK, Jeong MH, Cha KS, Kim HS, obotHRAi
- KMID: 2528025
- Korean Circ J.
- 2022 Apr;52(4):304-319.
- doi: 10.4070/kcj.2021.0293
Background and Objectives: De-escalation of dual-antiplatelet therapy through dose reduction of prasugrel improved net adverse clinical events (NACEs) after acute coronary syndrome (ACS), mainly through the reduction of bleeding without... -
- CITED
-
- Close
- SHARE
-
- Close
- Coronary Intravascular Lithotripsy Versus Rotational Atherectomy in an Asian Population: Clinical Outcomes in Real-World Patients
-
Wong JJ, Umapathy S, Keh YS, Lau YH, Yap J, Idu M, Chin CY, Fam JM, Liew BW, Chin CT, Wong PEH, Koh TH, Yeo KK
- KMID: 2528023
- Korean Circ J.
- 2022 Apr;52(4):288-300.
- doi: 10.4070/kcj.2021.0155
Background and Objectives: We compared real-world clinical outcomes of patients receiving intravascular lithotripsy (IVL) versus rotational atherectomy (RA) for heavily calcified coronary lesions. Methods: Fifty-three patients who received IVL from January... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Safety and Efficacy of Prolonged Dual Antiplatelet Therapy according to Baseline Anemia after Percutaneous Coronary Intervention
-
Kim HT, Lee JH, Nam JH, Lee CH, Son JW, Kim U, Park JS, Shin DG
- KMID: 2526553
- Yonsei Med J.
- 2022 Mar;63(3):211-219.
- doi: 10.3349/ymj.2022.63.3.211
Purpose: We aimed to evaluate the outcomes of prolonged dual antiplatelet therapy (DAPT) depending on baseline anemia after percutaneous coronary intervention (PCI). Materials and Methods: Among the 1470 study participants, 448... -
- CITED
-
- Close
- SHARE
-
- Close
- Functional Angioplasty: Definitions, Historical Overview, and Future Perspectives
-
Park H, Kang DY, Lee CW
- KMID: 2524168
- Korean Circ J.
- 2022 Jan;52(1):34-46.
- doi: 10.4070/kcj.2021.0363
Percutaneous coronary intervention (PCI) is used to treat obstructive coronary artery disease (CAD). The role of PCI is well defined in acute coronary syndrome, but that for stable CAD remains... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential Prognostic Implications of Pre- and Post-Stent Fractional Flow Reserve in Patients Undergoing Percutaneous Coronary Intervention
-
Zhang J, Hwang D, Yang S, Kim CH, Lee JM, Nam CW, Shin ES, Doh JH, Hoshino M, Hamaya R, Kanaji Y, Murai T, Zhang JJ, Ye F, Li X, Ge Z, Chen SL, Kakuta T, Koo BK
- KMID: 2524169
- Korean Circ J.
- 2022 Jan;52(1):47-59.
- doi: 10.4070/kcj.2021.0128
Background and Objectives: The influence of pre-intervention coronary physiologic status on outcomes post percutaneous coronary intervention (PCI) is not well known. We sought to investigate the prognostic implications of pre-PCI... -
- CITED
-
- Close
- SHARE
-
- Close
